Onco-Innovations Provides Shareholder Update Following Cboe Canada Investor Spotlight

Core Insights - Onco-Innovations Limited is focusing on enhancing cancer treatment technologies through innovation and AI-driven research [1] - The company outlined its strategic objectives for the upcoming year in a recent corporate update [1] - CEO Thomas O'Shaughnessy discussed the company's mission during an appearance on Cboe Canada's Investor Spotlight [1] Strategic Objectives - The company aims to implement strategic growth initiatives to further its mission [1] - Emphasis is placed on leveraging AI in research to improve cancer treatment [1] - The corporate update follows a significant public engagement to communicate its vision and plans [1]